FDA 483 - Pfizer Healthcare India Private Limited - October 18, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Pfizer Healthcare India Private Limited in Visakhapatnam, India, a sterile drug manufacturer, revealed significant deficiencies in equipment design, qualification, and maintenance. These issues led to particle contamination in drug products, resulting in multiple recalls and Field Alert Reports, and the presence of rust in manufacturing vessels. The firm failed to adequately qualify cleaning equipment and implement proper preventative maintenance actions.
ID · d4990f8b-8170-4751-8910-2b4c040a6367